For researchers working in this space, BPC-157 represents not merely a compound with documented effects, but a molecular tool for interrogating the intersection of NO signaling, angiogenesis, and cytoprotection in ways that have implications extending well beyond any single tissue or disease model
Holick MF
This generalization may explain initial particular extensions from inflammatory bowel research, throughout a short term period and long term therapy, toward the disturbances, such as multiple sclerosis search as well (5-7, 9)
Inflammopharmacology, 29, 487-498
If BPC-157 is the construction coordinator, TB-500 acts like the skilled workforce that actually rebuilds the structure
It is not a drug, supplement, or cosmetic